Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes: The ADVANCE trial

The optimal blood pressure (BP) goal in patients with diabetes remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10,948 people with diabetes, at moder...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hypertension
Auteurs principaux: Rahman, Faisal, McEvoy, John W., Ohkuma, Toshiaki, Marre, Michel, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Rodgers, Anthony, Selvin, Elizabeth, Williams, Bryan, Muntner, Paul, Chalmers, John, Woodward, Mark
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506385/
https://ncbi.nlm.nih.gov/pubmed/31030606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12414
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires